Novartis Stuck With Sanctions In Bone Drug MDL

Law360, New York (October 20, 2011, 3:05 PM EDT) -- A federal judge on Monday levied roughly $55,000 in sanctions against Novartis Pharmaceuticals Corp. in a multidistrict litigation over allegedly concealed health risks associated with two bone cancer drugs, saying the plaintiffs' requested attorneys' fees were needlessly high.

Novartis had been sanctioned in May 2010 for failing to come clean about the fact that it advertised the drugs, Aredia and Zometa, in consumer magazines, and Monday's order reimbursed the plaintiffs for additional discovery undertaken to determine how extensive the consumer advertising was. Magistrate Judge Joe Brown...
To view the full article, register now.




Case Information

Case Title

In Re: Aredia and Zometa Products Liability Litigation

Case Number



Tennessee Middle

Nature of Suit

Personal Inj. Prod. Liability


Todd J. Campbell

Date Filed

April 19, 2006

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.